Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency.

J Allergy Clin Immunol Pract

Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address:

Published: July 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271541	PMC
http://dx.doi.org/10.1016/j.jaip.2022.01.012	DOI Listing

Publication Analysis

targeted il-4rα

il-4rα blockade

blockade ameliorates

ameliorates refractory

refractory allergic

allergic eosinophilic

eosinophilic inflammation

inflammation patient

patient dysregulated

dysregulated tgf-β

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!